معرفی
Dawn Coletta, PhD, is an Associate Professor at the University of Arizona's College of Medicine, with shared appointments in the Division of Endocrinology, Diabetes and Metabolism (Department of Medicine) and the Department of Physiology. She joined the university in 2016 and previously held academic roles at Arizona State University and the University of Texas Health Science Center at San Antonio.
- Education: PhD from Aston University (Birmingham, UK)
- Postdoctoral Training: University of Texas Health Science Center at San Antonio
Dr. Coletta specializes in the molecular genetics and epigenetics of insulin resistance, a central factor in type 2 diabetes, obesity, and metabolic syndrome. Her lab employs cutting-edge techniques like global epigenetic mapping, DNA chip microarray analysis, and proteome studies to identify susceptibility genes and develop targeted therapies.
The 2025-2024 publications highlight her work on cardiometabolic risk factors in Latino populations, exercise-induced epigenetic changes, and genetic interactions in obesity. Her studies often integrate clinical interventions (e.g., bariatric surgery) with molecular profiling to uncover disease mechanisms.
Her research has been funded by prestigious organizations including the National Institutes of Health (NIH), American Diabetes Association (ADA), and American Heart Association (AHA). She actively contributes to curriculum development, teaching, and mentoring across multiple academic programs.
Dr. Coletta is affiliated with the UA Center for Disparities in Diabetes, Obesity and Metabolism and the Arizona Insulin Resistance Registry. Her work emphasizes population-specific factors in metabolic diseases and translational approaches to improve health outcomes.
